Maze Therapeutics, Inc. · NASDAQ:MAZE
Janus Henderson Group PLC reported a 5.70% stake in Maze Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 14, 2025
Janus Henderson Group PLC reported a 5.70% stake in Maze Therapeutics, Inc., 2,498,111 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G).
- Stake
- 5.70%
- Shares
- 2,498,111
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 5.70% | 2,498,111 |
Source
Related
- Maze Therapeutics, Inc.
- Janus Henderson Group PLC
- Maze Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Nov 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Form 4 · Bernstein Harold · Oct 2, 2026
- Form 4 · Coloma Jason V · Oct 2, 2026
- Form 4 · Dandekar Atul · Oct 1, 2026
- Form 4 · Bernstein Harold · Sep 8, 2026
- Form 4 · Bernstein Harold · Sep 4, 2026